跳至主要内容
临床试验/EUCTR2007-005547-17-GB
EUCTR2007-005547-17-GB进行中(未招募)不适用

Refeeding risks in patients requiring nutrition support. A twin centre double-blind randomised controlled trial of parenteral nutrition support. - Refeeding risks in patients requiring nutrition support

Southampton University Hospital NHS Trust0 个研究点目标入组 230 人开始时间: 2010年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.All consenting adults or those for whom consent can be gained from a close family member/friend or professional legal representative (minimum 18 years old) who require intravenous nutrition as assessed by the Southampton University Hospitals NHS Trust and the Royal Berkshire NHS Foundation Trust Nutrition Support Teams.
  • 2.Who do not require specialised parenteral nutrition regimens to meet their clinical needs.
  • 3.Who are at moderate or high risk of refeeding problems as defined by:
  • Moderate risk: 1 of the following criteria - BMI <18.5 kg/m2, unintentional weight loss >10% in 3-6 months or very little or no food intake for >5days.
  • High risk: 1 of the following criteria - BMI <16 kg/m2, unintentional weight loss >15%, very little nutritional intake for >10 days; or 2 of the following lesser criteria - BMI <18.5 kg/m2; weight loss >10%; very little nutritional intake for >5 days.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 115
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 115

排除标准

  • Patients at very high risk of re-feeding syndrome (2 or more of the NICE criteria (BMI<16, recent weight loss >15% body weight within-6 months, > 10 days with no nutritional intake) or patients with a BMI < 14))
  • If after careful clinical assessment the investigator feels that the patient is not at an unusually high risk from refeeding, they can be considered for inclusion if:
  • Magnesium level no greater than 0.2mmol below lower limit of normal
  • Phosphate level no greater than 0.2mmol below lower limit of normal
  • Potassium level no greater than 0.5mmol below lower limit of normal
  • Patients with established oral nutritional intake
  • Patients weighing 100kg or more, after adjusting for oedema.

研究者

发起方
Southampton University Hospital NHS Trust

相似试验